Back

The placebo effect in atrial fibrillation ablation: insights from a post hoc analysis of the PFA-SHAM trial

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation management: rhythm control, outcomes, and specific populations Cognitive Function and Autonomy in Patients with Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marek Hozman

Faculty Hospital Kralovske Vinohrady, Prague (Czechia)

5 More presentations in this session

Presentation thumbnail
Dynamic changes in anaemia and phenotype-specific risk of adverse outcomes in patients with atrial fibrillation treated with NOACs
Doctor A. Rigutini (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
The RIBAT-AFRICA-AF Registry (Registry Initiative Across Borders for Atrial Fibrillation in Africa)
Professor A. Moustaghfir (Casablanca, MA)
Abstract Slides Video
Presentation thumbnail
Comparative clinical effectiveness and safety of amiodarone versus dronedarone in patients with atrial fibrillation
Miss L. Liu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation and early-onset cognitive decline: a multicenter 14-year cross-sectional analysis of 1,641 patients in North Macedonia
Doctor V. Zhaku (Tetovo, MK)
Abstract Slides Video
Presentation thumbnail
Early rhythm control in patients with atrial fibrillation and cancer: a subgroup analysis of the EAST-AFNET 4 trial
Doctor D. Ismaili (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation management: rhythm control, outcomes, and specific populations

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Feasibility of atrial fibrillation burden quantification and its impact on quality-of-life after ablation procedure using continuous monitoring with a smartwatch
22 November 2025
thumbnail
Congress Presentation
SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation
2 September 2024
thumbnail
Congress Presentation
Sex differences in long-term clinical effectiveness after pulsed field ablation to treat atrial fibrillation. Sub-analysis of the global FARADISE registry
29 August 2025
thumbnail
Congress Presentation
Early patient-reported outcomes and quality of life improvements after PVI. A single center survey.
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources